Page last updated: 2024-08-24

nelfinavir and moxifloxacin

nelfinavir has been researched along with moxifloxacin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Clax, P; Damle, B; Fosser, C; Glue, P; Ito, K; Tran, A; Uderman, H	1
Beberok, A; Boryczka, S; Marciniec, K; Pęcak, P; Wrześniok, D	1

Reviews

1 review(s) available for nelfinavir and moxifloxacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for nelfinavir and moxifloxacin

Article	Year
Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study. Journal of clinical pharmacology, 2009, Volume: 49, Issue:3 Topics: Adult; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Fluoroquinolones; Heart Rate; HIV Protease Inhibitors; Humans; Long QT Syndrome; Middle Aged; Moxifloxacin; Nelfinavir; Polymorphism, Genetic; Quinolines	2009

Article

Year

Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study.

Journal of clinical pharmacology, 2009, Volume: 49, Issue:3

Topics: Adult; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Fluoroquinolones; Heart Rate; HIV Protease Inhibitors; Humans; Long QT Syndrome; Middle Aged; Moxifloxacin; Nelfinavir; Polymorphism, Genetic; Quinolines

2009

Other Studies

2 other study(ies) available for nelfinavir and moxifloxacin

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis. Pharmacological reports : PR, 2020, Volume: 72, Issue:6 Topics: Antiviral Agents; Binding Sites; Chloroquine; Ciprofloxacin; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Moxifloxacin; Nelfinavir; Protein Binding; SARS-CoV-2	2020

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.

Pharmacological reports : PR, 2020, Volume: 72, Issue:6

Topics: Antiviral Agents; Binding Sites; Chloroquine; Ciprofloxacin; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Moxifloxacin; Nelfinavir; Protein Binding; SARS-CoV-2

2020